Asprosin is a recently discovered fasting-induced hormone that promotes hepatic glucose production. Here we demonstrate that asprosin in the circulation crosses the blood–brain barrier and directly activates orexigenic AgRP+ neurons via a cAMP-dependent pathway. This signaling results in inhibition of downstream anorexigenic proopiomelanocortin (POMC)-positive neurons in a GABA-dependent manner, which then leads to appetite stimulation and a drive to accumulate adiposity and body weight. In humans, a genetic deficiency in asprosin causes a syndrome characterized by low appetite and extreme leanness; this is phenocopied by mice carrying similar mutations and can be fully rescued by asprosin. Furthermore, we found that obese humans and mice had pathologically elevated concentrations of circulating asprosin, and neutralization of asprosin in the blood with a monoclonal antibody reduced appetite and body weight in obese mice, in addition to improving their glycemic profile. Thus, in addition to performing a glucogenic function, asprosin is a centrally acting orexigenic hormone that is a potential therapeutic target in the treatment of both obesity and diabetes.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from $8.99

All prices are NET prices.


  1. 1.

    et al. Asprosin, a fasting-induced glucogenic protein hormone. Cell 165, 566–579 (2016).

  2. 2.

    , , & Body fat distribution and metabolic variables in patients with neonatal progeroid syndrome. Am. J. Med. Genet. A. 143A, 1421–1430 (2007).

  3. 3.

    et al. Neonatal progeroid variant of Marfan syndrome with congenital lipodystrophy results from mutations at the 3′ end of FBN1 gene. Eur. J. Med. Genet. 57, 230–234 (2014).

  4. 4.

    & Marfan's syndrome. Lancet 366, 1965–1976 (2005).

  5. 5.

    & Indirect calorimetry in laboratory mice and rats: principles, practical considerations, interpretation and perspectives. Am. J. Physiol. Regul. Integr. Comp. Physiol. 303, R459–R476 (2012).

  6. 6.

    , & AgRP neurons are sufficient to orchestrate feeding behavior rapidly and without training. Nat. Neurosci. 14, 351–355 (2011).

  7. 7.

    et al. Rapid, reversible activation of AgRP neurons drives feeding behavior in mice. J. Clin. Invest. 121, 1424–1428 (2011).

  8. 8.

    , , & NPY–AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science 310, 683–685 (2005).

  9. 9.

    et al. A role for ghrelin in the central regulation of feeding. Nature 409, 194–198 (2001).

  10. 10.

    et al. Palatability can drive feeding independent of AgRP neurons. Cell Metab. 22, 646–657 (2015).

  11. 11.

    , , & Deconstruction of a neural circuit for hunger. Nature 488, 172–177 (2012).

  12. 12.

    , , , & Synaptic release of GABA by AgRP neurons is required for normal regulation of energy balance. Nat. Neurosci. 11, 998–1000 (2008).

  13. 13.

    et al. A neural basis for melanocortin-4 receptor–regulated appetite. Nat. Neurosci. 18, 863–871 (2015).

  14. 14.

    , , , & Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385, 165–168 (1997).

  15. 15.

    et al. Gs-coupled GPCR signaling in AgRP neurons triggers sustained increase in food intake. Nat. Commun. 7, 10268 (2016).

  16. 16.

    , , & Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J. Am. Diet. Assoc. 102, 1621–1630 (2002).

  17. 17.

    , & Energy requirements of lactating women derived from doubly labeled water and milk energy output. J. Nutr. 131, 53–58 (2001).

  18. 18.

    Use of the doubly labeled water method for measurement of energy expenditure, total body water, water intake, and metabolizable energy intake in humans and small animals. Can. J. Physiol. Pharmacol. 67, 1190–1198 (1989).

  19. 19.

    Measurement of energy expenditure in free-living humans by using doubly labeled water. J. Nutr. 118, 1278–1289 (1988).

  20. 20.

    , & Comparison of multiple-pass 24-hour recall estimates of energy intake with total energy expenditure determined by the doubly labeled water method in young children. J. Am. Diet. Assoc. 96, 1140–1144 (1996).

  21. 21.

    National Research Council. Guide for the Care and Use of Laboratory Animals 8th edn. (The National Academies Press, 2011).

  22. 22.

    , , & NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science 310, 683–685 (2005).

  23. 23.

    , & Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics 30, 1473–1475 (2014).

  24. 24.

    et al. Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 304, 110–115 (2004).

  25. 25.

    et al. Serotonin 2C receptors in pro-opiomelanocortin neurons regulate energy and glucose homeostasis. J. Clin. Invest. 123, 5061–5070 (2013).

  26. 26.

    et al. Estrogens stimulate serotonin neurons to inhibit binge-like eating in mice. J. Clin. Invest. 124, 4351–4362 (2014).

  27. 27.

    et al. Activation of serotonin 2C receptors in dopamine neurons inhibits binge-like eating in mice. Biol. Psychiatry 81, 737–747 (2017).

  28. 28.

    et al. Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis. Neuron 49, 191–203 (2006).

  29. 29.

    et al. FoxO1 target Gpr17 activates AgRP neurons to regulate food intake. Cell 149, 1314–1326 (2012).

  30. 30.

    et al. Melanocortin 4 receptors reciprocally regulate sympathetic and parasympathetic preganglionic neurons. Cell 152, 612–619 (2013).

  31. 31.

    et al. Directed differentiation of forebrain GABA interneurons from human pluripotent stem cells. Nat. Protoc. 8, 1670–1679 (2013).

  32. 32.

    et al. Fasting activation of AgRP neurons requires NMDA receptors and involves spinogenesis and increased excitatory tone. Neuron 73, 511–522 (2012).

  33. 33.

    et al. Apolipoprotein A-IV inhibits AgRP–NPY neurons and activates pro-opiomelanocortin neurons in the arcuate nucleus. Neuroendocrinology 103, 476–488 (2016).

Download references


This work was supported in part by the Baylor College of Medicine Mouse Metabolism Core (funded by NIH grant P30 DK079638), the Protein and Monoclonal Antibody Production Core (funded by NIH grant P30 CA125123), and the Mouse Phenotyping Core (funded by NIH grant UM1HG006348). Mammalian asprosin was provided by the University of North Carolina at Chapel Hill Protein Expression and Purification Core (funded by NIH grant P30 CA016086). Support was also provided by American Heart Association postdoctoral fellowships 16POST29630010 (C.D.) and 16POST27260254 (C.W.), the American Diabetes Association (grants 1-17-PDF-138 (Y.H.) and 1-17-JDF-009 (K.J.P.)), the NIDDK (grants 1R01DK111631 (K.J.P.), DK075087 (M.J.K.), DK101379 (Y.X.), and 1K08DK102529 (A.R.C.)), the NLM (grant LM012806; Z.Z.), the NHGRI Baylor–Johns Hopkins Center for Mendelian Genomics (grant UM1 HG006542; V.R.S.), the R.P. Doherty, Jr. –Welch Chair in Science Q-0022 (D.D.M.), the Intramural Research Program of the NIH (M.J.K.), and the USDA–CRIS (3092-5-001-059; Y.X.). A.R.C. is also supported by the Chao Physician-scientist Award, the Caroline Wiess Law scholar award, and a departmental laboratory startup package.

Author information

Author notes

    • Clemens Duerrschmid
    • , Yanlin He
    •  & Chunmei Wang

    These authors contributed equally to this work.

    • Yong Xu
    •  & Atul R Chopra

    These authors jointly directed this work.


  1. Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.

    • Clemens Duerrschmid
    • , Juan C Bournat
    • , Chase Romere
    • , Pradip K Saha
    • , Mark E Lee
    • , Kevin J Phillips
    • , David D Moore
    • , Yong Xu
    •  & Atul R Chopra
  2. USDA–ARS Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.

    • Yanlin He
    • , Chunmei Wang
    • , Monica Farias
    • , Qi Wu
    • , Nancy F Butte
    •  & Yong Xu
  3. Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, Maryland, USA.

    • Chia Li
    •  & Michael J Krashes
  4. National Institute on Drug Abuse (NIDA), National Institutes of Health, Baltimore, Maryland, USA.

    • Chia Li
    •  & Michael J Krashes
  5. Kennedy Krieger Institute, Baltimore, Maryland, USA.

    • Mahim Jain
  6. Center for Precision Health, School of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, Texas, USA.

    • Peilin Jia
    •  & Zhongming Zhao
  7. Department of Internal Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA.

    • Dianna M Milewicz
  8. Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.

    • V Reid Sutton
    •  & Atul R Chopra


  1. Search for Clemens Duerrschmid in:

  2. Search for Yanlin He in:

  3. Search for Chunmei Wang in:

  4. Search for Chia Li in:

  5. Search for Juan C Bournat in:

  6. Search for Chase Romere in:

  7. Search for Pradip K Saha in:

  8. Search for Mark E Lee in:

  9. Search for Kevin J Phillips in:

  10. Search for Mahim Jain in:

  11. Search for Peilin Jia in:

  12. Search for Zhongming Zhao in:

  13. Search for Monica Farias in:

  14. Search for Qi Wu in:

  15. Search for Dianna M Milewicz in:

  16. Search for V Reid Sutton in:

  17. Search for David D Moore in:

  18. Search for Nancy F Butte in:

  19. Search for Michael J Krashes in:

  20. Search for Yong Xu in:

  21. Search for Atul R Chopra in:


A.R.C. and Y.X. conceptualized the study; C.D., Y.H., C.W., C.L., J.C.B., C.R., P.K.S., M.J.K., and A.R.C. performed experiments; V.R.S., N.F.B., and A.R.C. performed clinical assessment of individuals with NPS; M.E.L., K.J.P., M.J., M.F., Q.W., D.M.M., and D.D.M. provided resources; P.J. and Z.Z. performed the ANCOVA analysis; and A.R.C. wrote the manuscript.

Competing interests

The authors declare no competing financial interests.

Corresponding authors

Correspondence to Yong Xu or Atul R Chopra.

Supplementary information

PDF files

  1. 1.

    Supplementary Figures and Tables

    Supplementary Figures 1–9 and Supplementary Tables 1–2

  2. 2.

    Life Sciences Reporting Summary

About this article

Publication history